This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory vaccine eligibility review

UK Meningitis B Vaccine Eligibility Review

Analysis based on 7 articles · First reported Mar 19, 2026 · Last updated Mar 20, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The potential expansion of the menB vaccine program could increase demand for pharmaceutical companies producing the vaccine. It also highlights a public health issue that could influence healthcare spending and policy within the United Kingdom.

Pharmaceuticals Healthcare

Gaynor Simpson, whose son Ross nearly died from meningitis B, is advocating for the United Kingdom===National Health Service (NHS) to expand its menB vaccine program to include teenagers and young people. This call comes amid a meningitis outbreak in Kent, which has resulted in two deaths. The menB vaccine was introduced for babies in 2015, but older children are not covered. UK Health Secretary Wes Streeting has asked the United Kingdom===Joint Committee on Vaccination and Immunisation (JCVI) to re-examine vaccine eligibility, as the JCVI previously deemed a catch-up campaign not cost-effective. Meningitis Now, an NGO, is also campaigning for wider vaccination and a booster program by 2030.

95 Wes Streeting asked to re-examine meningitis vaccine eligibility United Kingdom===Joint Committee on Vaccination and Immunisation
90 Gaynor Simpson backed calls for wider menB vaccination program United Kingdom===National Health Service
85 Meningitis Now called for menB vaccine for teenagers and booster program United Kingdom===National Health Service
govactor
The United Kingdom===National Health Service (NHS) is the primary healthcare provider in the United Kingdom and is responsible for vaccine programs. The current debate centers on whether the NHS will expand its menB vaccine eligibility.
Importance 90 Sentiment 10
govactor
The United Kingdom===Joint Committee on Vaccination and Immunisation (JCVI) is the advisory body that previously deemed a menB catch-up campaign not cost-effective. UK Health Secretary Wes Streeting has asked the JCVI to re-examine eligibility for meningitis vaccines.
Importance 85 Sentiment 10
per
Gaynor Simpson is advocating for wider availability of the menB vaccine on the NHS after her son, Ross, nearly died from meningitis B. Her personal story and advocacy are central to the calls for re-examining vaccine eligibility.
Importance 80 Sentiment 20
per
Wes Streeting, the UK Health Secretary, has requested that the United Kingdom===Joint Committee on Vaccination and Immunisation re-examine the eligibility for meningitis vaccines. His intervention could lead to policy changes.
Importance 75 Sentiment 10
ngo
Meningitis Now is actively campaigning for the menB vaccine to be available to teenagers and young people on the NHS, and for a booster program by 2030. They are a key organization driving the policy discussion.
Importance 70 Sentiment 30
govactor
The United Kingdom===United Kingdom Health Security Agency (UKHSA) is monitoring the meningitis outbreak in Kent, confirming cases and providing data that informs the discussion around vaccine eligibility.
Importance 60 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.